Ensysce Biosciences Inc. (ENSC)
NASDAQ: ENSC
· Real-Time Price · USD
2.08
0.02 (0.97%)
At close: Aug 15, 2025, 3:59 PM
2.09
0.64%
After-hours: Aug 15, 2025, 05:36 PM EDT
Ensysce Biosciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 2.21M | 3.05M | 3.5M | 4.15M | 1.04M | 3.4M | 1.12M | 1.46M | 3.83M | 1.42M | 3.15M | 4.5M | 3.73M | 8.44M | 12.26M | 6.85M | 8.01M | 18.03K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.69M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.69M |
Other Long-Term Assets | 292.86K | 210.88K | 252.55K | 294.22K | 335.88K | 377.55K | 419.22K | 458.17K | 491.68K | 525.2K | 558.72K | 592.24K | 743.99K | 695.48K | -24.72B | -31.54B | 838.09K | 3.78K |
Receivables | 1.2M | 22K | 124.11K | 1.78M | 224.22K | 96.22K | 97.56K | 107.74K | 107.58K | 289.31K | 276.82K | 140.81K | 276.63K | 808.6K | 441.72K | 86.87K | 75.35K | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | -97.56K | n/a | n/a | n/a | -276.82K | n/a | n/a | n/a | -441.72K | n/a | n/a | n/a |
Other Current Assets | 1.87M | 222.7K | 18K | 18K | 603.63K | 792.75K | 651.03K | 2.72K | 1.92M | 1.67M | 1.33M | 2.36M | 2.37M | 473.08K | 2.15M | 906.41K | 9.41K | n/a |
Total Current Assets | 5.28M | 4.4M | 5.34M | 9.09M | 2.46M | 4.7M | 2.29M | 2.76M | 5.86M | 3.37M | 5.3M | 7.66M | 7.19M | 11.66M | 15.66M | 8.92M | 8.36M | 228.21K |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.72K | 10.87K | 19.02K | 27.16K | 35.31K | 10.25K | 17.61K | 24.72B | 31.54B | 50.00 | 100.00 |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.88K |
Total Long-Term Assets | 292.86K | 210.88K | 252.55K | 294.22K | 335.88K | 377.55K | 419.22K | 460.88K | 502.55K | 544.22K | 585.88K | 627.55K | 754.24K | 713.09K | 754.76K | 796.42K | 838.14K | 12.75M |
Total Assets | 5.57M | 4.61M | 5.6M | 9.38M | 2.8M | 5.07M | 2.71M | 3.22M | 6.36M | 3.91M | 5.89M | 8.29M | 7.95M | 12.37M | 16.42M | 9.72M | 9.2M | 12.98M |
Account Payables | 1.04M | 615.29K | 1.36M | 1.97M | 481.97K | 981.72K | 1.94M | 916.42K | 1.27M | 1.6M | 2.94M | 1.29M | 3.05M | 959.63K | 301.1K | 471.86K | 3.14M | 2.23M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 24.87K | n/a | n/a | -6.76M |
Short-Term Debt | 424.52K | 257.38K | 301.66K | 387.18K | 454.46K | 245.97K | 854.7K | 350.93K | 456.66K | 19.12K | 4.27M | 7.59M | 2.52M | 6.07M | 12.75M | 2.8M | 466.06K | n/a |
Other Current Liabilities | 2.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.93K | -19.12K | n/a | 2.7M | n/a | n/a | n/a | n/a | n/a | -2.68M |
Total Current Liabilities | 2.51M | 1.76M | 2.21M | 2.8M | 1.31M | 1.64M | 3.33M | 2.03M | 2.52M | 3.98M | 9.46M | 11.91M | 8.25M | 8.8M | 16.48M | 7.03M | 4.03M | 319.18K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 140.15K | 1.39M | 137.32K | 1.59M | 4.44M | 2.11M | n/a | n/a |
Other Long-Term Liabilities | n/a | 130.18K | 10.1K | 3.21K | 9.62K | 17.43K | 26.39K | 30.47K | 47.7K | 91.32K | 310.35K | 1.41M | 360.8K | 871.41K | 3.65M | 957.1K | n/a | 10.77M |
Total Long-Term Liabilities | n/a | 130.18K | 10.1K | 3.21K | 9.62K | 17.43K | 26.39K | 30.47K | 47.7K | 91.32K | 450.49K | 2.8M | 498.11K | 2.46M | 8.09M | 3.07M | n/a | 10.77M |
Total Liabilities | 1.03K | 1.89M | 2.22M | 2.8M | 1.32M | 1.65M | 3.36M | 2.06M | 2.56M | 4.07M | 9.91M | 14.71M | 8.75M | 11.26M | 24.58M | 10.1M | 4.03M | 11.09M |
Total Debt | 424.52K | 257.38K | 301.66K | 387.18K | 454.46K | 245.97K | 854.7K | 353.66K | 456.66K | 19.12K | 4.41M | 8.98M | 2.67M | 7.68M | 12.75M | 4.94M | 476.25K | 460K |
Common Stock | 241.00 | 165.00 | 136.00 | 1.39K | 815.00 | 733.00 | 21.00 | 287.00 | 267.00 | 128.00 | 642.00 | 221.00 | 3.55K | 3K | 2.46K | 2.42K | 2.42K | 622.00 |
Retained Earnings | -133.22M | -131.49M | -129.54M | -125.98M | -126.64M | -124.67M | -121.56M | -118.05M | -115.36M | -113.13M | -110.93M | -105.41M | -95.51M | -87.51M | -85.85M | -75.01M | -57.84M | -2.92M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 |
Shareholders Equity | 3.39M | 3.05M | 3.71M | 6.91M | 1.81M | 3.75M | -322.86K | 1.49M | 4.12M | 166.72K | -4.03M | -6.09M | -491.64K | 1.39M | -8.16M | -105.69K | 5.41M | 1.89M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.69M |